Global and Region Biodefense Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Biodefense market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biodefensemarket, defines the market attractiveness level of Biodefense market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biodefense industry, describes the types of Biodefense market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biodefense market and the development prospects and opportunities of Biodefense industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biodefense market in Chapter 13.

    By Player:

    • DynPort Vaccine

    • Emergent Biosolutions

    • SIGA Technologies

    • PharmAthene

    • Hytest

    • Soligenix

    • Ichor Medical Systems

    • Cleveland BioLabs

    • Alnylam Pharmaceuticals

    • Dynavax Technologies

    • Elusys Therapeutics

    • Arbutus Biopharma

    • Xoma Corporation

    • Aeolus Pharmaceuticals

    • Sanofi

    • Achaogen

    • Bavarian Nordic

    • GSK

    By Type:

    • Anthrax

    • Smallpox

    • Botulism

    • Radiation/Nuclear

    • Others

    By End-User:

    • Others

    • Others

    • Others

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biodefense Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biodefense Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biodefense Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biodefense Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biodefense Market Analysis and Outlook to 2022

    • 7.1 Global Biodefense Consumption (2017-2022)

    • 7.2 United States Biodefense Consumption (2017-2022)

    • 7.3 Europe Biodefense Consumption (2017-2022)

    • 7.4 China Biodefense Consumption (2017-2022)

    • 7.5 Japan Biodefense Consumption (2017-2022)

    • 7.6 India Biodefense Consumption (2017-2022)

    • 7.7 South Korea Biodefense Consumption (2017-2022)

    8 Region and Country-wise Biodefense Market Analysis and Outlook to 2028

    • 8.1 Global Biodefense Consumption Forecast (2022-2028)

    • 8.2 United States Biodefense Consumption Forecast (2022-2028)

    • 8.3 Europe Biodefense Consumption Forecast (2022-2028)

    • 8.4 China Biodefense Consumption Forecast (2022-2028)

    • 8.5 Japan Biodefense Consumption Forecast (2022-2028)

    • 8.6 India Biodefense Consumption Forecast (2022-2028)

    • 8.7 South Korea Biodefense Consumption Forecast (2022-2028)

    9 Global Biodefense Market Outlook by Types and Applications to 2022

    • 9.1 Global Biodefense Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anthrax Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Smallpox Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Botulism Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Radiation/Nuclear Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biodefense Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Others Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Biodefense Market Outlook by Types and Applications to 2028

    • 10.1 Global Biodefense Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Anthrax Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Smallpox Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Botulism Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Radiation/Nuclear Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biodefense Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biodefense Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biodefense Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biodefense Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biodefense Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biodefense Market Competitive Analysis

    • 14.1 DynPort Vaccine

      • 14.1.1 DynPort Vaccine Company Details

      • 14.1.2 DynPort Vaccine Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 DynPort Vaccine Biodefense Product and Service

    • 14.2 Emergent Biosolutions

      • 14.2.1 Emergent Biosolutions Company Details

      • 14.2.2 Emergent Biosolutions Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Emergent Biosolutions Biodefense Product and Service

    • 14.3 SIGA Technologies

      • 14.3.1 SIGA Technologies Company Details

      • 14.3.2 SIGA Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SIGA Technologies Biodefense Product and Service

    • 14.4 PharmAthene

      • 14.4.1 PharmAthene Company Details

      • 14.4.2 PharmAthene Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 PharmAthene Biodefense Product and Service

    • 14.5 Hytest

      • 14.5.1 Hytest Company Details

      • 14.5.2 Hytest Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hytest Biodefense Product and Service

    • 14.6 Soligenix

      • 14.6.1 Soligenix Company Details

      • 14.6.2 Soligenix Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Soligenix Biodefense Product and Service

    • 14.7 Ichor Medical Systems

      • 14.7.1 Ichor Medical Systems Company Details

      • 14.7.2 Ichor Medical Systems Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Ichor Medical Systems Biodefense Product and Service

    • 14.8 Cleveland BioLabs

      • 14.8.1 Cleveland BioLabs Company Details

      • 14.8.2 Cleveland BioLabs Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Cleveland BioLabs Biodefense Product and Service

    • 14.9 Alnylam Pharmaceuticals

      • 14.9.1 Alnylam Pharmaceuticals Company Details

      • 14.9.2 Alnylam Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Alnylam Pharmaceuticals Biodefense Product and Service

    • 14.10 Dynavax Technologies

      • 14.10.1 Dynavax Technologies Company Details

      • 14.10.2 Dynavax Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Dynavax Technologies Biodefense Product and Service

    • 14.11 Elusys Therapeutics

      • 14.11.1 Elusys Therapeutics Company Details

      • 14.11.2 Elusys Therapeutics Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Elusys Therapeutics Biodefense Product and Service

    • 14.12 Arbutus Biopharma

      • 14.12.1 Arbutus Biopharma Company Details

      • 14.12.2 Arbutus Biopharma Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Arbutus Biopharma Biodefense Product and Service

    • 14.13 Xoma Corporation

      • 14.13.1 Xoma Corporation Company Details

      • 14.13.2 Xoma Corporation Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Xoma Corporation Biodefense Product and Service

    • 14.14 Aeolus Pharmaceuticals

      • 14.14.1 Aeolus Pharmaceuticals Company Details

      • 14.14.2 Aeolus Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Aeolus Pharmaceuticals Biodefense Product and Service

    • 14.15 Sanofi

      • 14.15.1 Sanofi Company Details

      • 14.15.2 Sanofi Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Sanofi Biodefense Product and Service

    • 14.16 Achaogen

      • 14.16.1 Achaogen Company Details

      • 14.16.2 Achaogen Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Achaogen Biodefense Product and Service

    • 14.17 Bavarian Nordic

      • 14.17.1 Bavarian Nordic Company Details

      • 14.17.2 Bavarian Nordic Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Bavarian Nordic Biodefense Product and Service

    • 14.18 GSK

      • 14.18.1 GSK Company Details

      • 14.18.2 GSK Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 GSK Biodefense Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biodefense

    • Figure Biodefense Picture

    • Table Global Biodefense Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biodefense Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biodefense Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biodefense Consumption by Country (2017-2022)

    • Figure United States Biodefense Consumption and Growth Rate (2017-2022)

    • Table Europe Biodefense Consumption and Growth Rate (2017-2022)

    • Figure China Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Japan Biodefense Consumption and Growth Rate (2017-2022)

    • Figure India Biodefense Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Global Biodefense Consumption Forecast by Country (2022-2028)

    • Figure United States Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anthrax Consumption and Growth Rate (2017-2022)

    • Figure Global Smallpox Consumption and Growth Rate (2017-2022)

    • Figure Global Botulism Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation/Nuclear Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anthrax Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Smallpox Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Botulism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation/Nuclear Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biodefense Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biodefense Export by Region (Top 5 Countries) (2017-2028)

    • Table DynPort Vaccine (Foundation Year, Company Profile and etc.)

    • Table DynPort Vaccine Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table DynPort Vaccine Biodefense Product and Service

    • Table Emergent Biosolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent Biosolutions Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Biosolutions Biodefense Product and Service

    • Table SIGA Technologies (Foundation Year, Company Profile and etc.)

    • Table SIGA Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIGA Technologies Biodefense Product and Service

    • Table PharmAthene (Foundation Year, Company Profile and etc.)

    • Table PharmAthene Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmAthene Biodefense Product and Service

    • Table Hytest (Foundation Year, Company Profile and etc.)

    • Table Hytest Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hytest Biodefense Product and Service

    • Table Soligenix (Foundation Year, Company Profile and etc.)

    • Table Soligenix Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Soligenix Biodefense Product and Service

    • Table Ichor Medical Systems (Foundation Year, Company Profile and etc.)

    • Table Ichor Medical Systems Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ichor Medical Systems Biodefense Product and Service

    • Table Cleveland BioLabs (Foundation Year, Company Profile and etc.)

    • Table Cleveland BioLabs Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cleveland BioLabs Biodefense Product and Service

    • Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Biodefense Product and Service

    • Table Dynavax Technologies (Foundation Year, Company Profile and etc.)

    • Table Dynavax Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dynavax Technologies Biodefense Product and Service

    • Table Elusys Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Elusys Therapeutics Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elusys Therapeutics Biodefense Product and Service

    • Table Arbutus Biopharma (Foundation Year, Company Profile and etc.)

    • Table Arbutus Biopharma Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arbutus Biopharma Biodefense Product and Service

    • Table Xoma Corporation (Foundation Year, Company Profile and etc.)

    • Table Xoma Corporation Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xoma Corporation Biodefense Product and Service

    • Table Aeolus Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Aeolus Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aeolus Pharmaceuticals Biodefense Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Biodefense Product and Service

    • Table Achaogen (Foundation Year, Company Profile and etc.)

    • Table Achaogen Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Achaogen Biodefense Product and Service

    • Table Bavarian Nordic (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Biodefense Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Biodefense Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.